Researchers at Mayo Clinic in Florida have uncovered a toxic cellular process by which a protein that maintains the health of neurons becomes deficient and can lead to dementia. The findings shed new light on the link between culprits implicated in two devastating neurological diseases: and amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. The study is published Dec. 10 in the online issue of Proceedings of the National Academy of Sciences.
There is no cure for frontotemporal dementia, a disorder that affects personality, behavior and language and is second only to Alzheimer's disease as the most common form of early-onset dementia. While much research is devoted to understanding the role of each defective protein in these diseases, the team at Mayo Clinic took a new approach to examine the interplay between TDP-43, a protein that regulates messenger ribonucleic acid (mRNA) — biological molecules that carry the information of genes and are used by cells to guide protein synthesis — and sortilin, which regulates the protein progranulin.
"We sought to investigate how TDP-43 regulates the levels of the protein progranulin, given that extreme progranulin levels at either end of the spectrum, too low or too high, can respectively lead to neurodegeneration or cancer," says the study's lead investigator, Mercedes Prudencio, Ph.D., a neuroscientist at the Mayo Clinic campus in Florida.
The neuroscientists found that a lack of the protein TDP-43, long implicated in frontotemporal dementia and amyotrophic lateral sclerosis, leads to elevated levels of defective sortilin mRNA. The research team is the first to identify significantly elevated levels of the defective sortilin mRNA in autopsied human brain tissue of frontotemporal dementia/TDP cases, the most common subtype of the disease.
"We found a lack of TDP-43 disrupts the cellular process called mRNA splicing that precedes protein synthesis, resulting in the generation of a defective sortilin protein," Dr. Prudencio says. "More important, the defective sortilin binds to progranulin and as a result deprives neurons of progranulin's protective effects that stave off the cell death associated with disease."
By improving the scientific community's understanding of the biological processes leading to frontotemporal dementia, the researchers have also paved the way for the development of new therapies to prevent or combat the disease, says Leonard Petrucelli, Ph.D., chair of the Department of Neuroscience at Mayo Clinic in Florida, who led the research.
Mayo Clinic: http://www.mayoclinic.org/news
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Some, like dolphins or chimps, are sophisticated communicators. But do they have their own languages? Its a question that misses the point
Grey and harbour seals in the North Sea weave in and out of offshore wind farms in search of fish, which gather around turbines
Researchers have created wheat that is resistant to a common disease, using advanced gene editing methods.
An archaeological dig uncovers new clues about life and death in America's early history
Ted Stanley is giving $650 million to the Broad Institute of MIT and Harvard to find and treat the genetic underpinnings of mental illnesses. His son has bipolar disorder.
As far as agricultural genome research goes, this may be the best thing since sliced bread - wheat bread, that is.
The discovery and culturing of bacteria that eat and excrete electrons means we may soon find out just how little electricity fundamental life requires
The spectacularly well-preserved prehistoric sea creature sported compound eyes, body armor and two spiky claws for grabbing prey
The Beagle's library of more than 400 books has been reconstructed and made freely available in digital form
When the gorilla Willie B. had to move to a tiny cage at the Atlanta Zoo for six months, the vet staff decided to put Thorazine in the Coca-Cola he drank in the morning. Willie responded to the drug as many institutionalized humans do: He shuffled back and forth across his cage with dulled eyes.